Methyldopa

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Methyldopa and local guidelines before prescribing.

Central antihypertensive

Mechanism

Central alpha-2 agonist (false neurotransmitter).

Uses

Hypertension in pregnancy.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Sedation, depression, haemolytic anaemia, hepatitis, postural hypotension.

Interactions

Iron reduces absorption; lithium toxicity.

Contraindications and cautions

Depression, liver disease, phaeochromocytoma

Monitoring

LFT, FBC, Coombs

Pregnancy and breastfeeding

Used in pregnancy

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

Coombs test may become positive; used when labetalol or nifedipine unsuitable.

More from the textbook: uses, cautions and other points
Where it is discussed in the book